A

Amgen

Makes biotech medicines for serious illnesses

Director, Disease Area Strategy Lead - General Medicine

Product MarketingConfirmed live in the last 24 hours
Full-timeRemote in USARemote

About the Job

Requirements

  • A doctorate degree and 4 years of marketing and/or commercial experience, or a master’s degree and 7 years of marketing and/or commercial experience, or a bachelor’s degree and 9 years of marketing and/or commercial experience.
  • Experience in the biopharmaceutical industry, life sciences strategy consulting, or a related field, with demonstrated ability to solve complex strategic and commercial problems.
  • Experience in New Product Planning, pipeline commercial strategy, portfolio strategy, commercial development, strategy consulting, forecasting, market research, analytics, business development, or related disciplines, with ability to integrate across functions.
  • Experience evaluating early-stage assets, disease opportunities, or product concepts, including patient need, future treatment landscapes, differentiation, positioning, and commercial potential.
  • Strong scientific and clinical learning agility, with the ability to engage credibly with scientific and clinical experts and translate technical information into strategic implications.
  • Strong qualitative and quantitative strategic judgment, including the ability to structure ambiguous problems, identify decision-critical assumptions, evaluate tradeoffs, and develop recommendations despite uncertainty.
  • Demonstrated ability to lead through influence and build trusted cross-functional partnerships, creating direction, alignment, and momentum across Research, Development, Medical, Commercial, and other functions.

Responsibilities

  • Lead the ongoing development and evolution of the General Medicine therapeutic area strategy, including Cardiovascular Disease and Bone Health, in partnership with the Executive Director Disease Area Strategy Lead and cross-functional leaders.
  • Translate therapeutic area ambitions into disease and franchise priorities, portfolio implications, investment priorities, and strategic actions.
  • Maintain a forward-looking view of evolving science, standards of care, patient and customer needs, competitive dynamics, and the company’s portfolio, and assess implications for strategy.
  • Assess where the company has a differentiated right to win, where opportunities warrant investment, and where investment should remain selective or be deprioritized.
  • Ensure asset and program decisions remain connected to broader therapeutic area and franchise strategy, including explicit tradeoffs across assets, diseases, mechanisms, and platforms.
  • Partner with Business Development and Commercial Business Development to inform external innovation priorities and opportunity assessments in the context of General Medicine therapeutic area and portfolio strategy.
  • Serve as the Commercial strategic lead and representative for early pipeline projects and programs, developing and representing the Commercial point of view through program evolution and governance.
  • Partner with Research, Development, Medical, and other functions to define the patient population, unmet need, future treatment context, differentiation requirements, product profile, and evidence needs for compelling opportunities.
  • Identify critical strategic and commercial questions early enough to influence research, development, and investment choices.
  • Assess whether scientific and technical success can translate into a differentiated and commercially attractive medicine, and develop recommendations regarding progression, investment, partnering, or discontinuation.
  • Lead cross-functional teams in creating target product profiles and development strategies that reflect patient needs, future standards of care, and meaningful differentiation.
  • Lead New Product Planning and early commercial assessments for assigned programs, including market and competitive assessment, patient segmentation, positioning, forecasting, and commercial opportunity assessment to inform product and investment strategy.
  • Drive cross-functional opportunity assessments, including forecast estimates, eNPVs, and competitive landscapes, across development stages to inform indication prioritization, sequencing, and patient impact expansion opportunities.
  • Partner across Research, Development, Medical, Competitive Intelligence, Business Analytics and Insights, Commercial, and other functions to drive complex asset- and therapeutic-area-level strategic work, bring together relevant expertise, challenge assumptions, build alignment, and move critical questions toward decisions.
  • Structure ambiguous strategic questions and identify the issues, assumptions, and evidence most important to the decision.
  • Integrate qualitative and quantitative evidence, including scientific and clinical data, customer and key opinion leader insights, competitive intelligence, epidemiology, market research, real-world evidence, forecasting, and analytics.
  • Develop clear recommendations despite uncertainty, communicate complex conclusions concisely, and influence effectively without formal authority to create clarity, alignment, and momentum.

Desired Qualifications

  • An advanced degree such as an MBA, PhD, PharmD, MD, MPH, or another relevant scientific or business discipline.
  • Therapeutic area experience in cardiovascular disease, bone health, or other General Medicine areas, with demonstrated ability to rapidly build expertise across new diseases and scientific areas.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs